Upcoming catalysts and material SEC filings for Altimmune, Inc. (ALT). 1 upcoming catalyst.
Trial readout (estimated)
Q3 2026 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
No recent filings for ALT.